Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Completed Initiated Apr 29, 2024 (2 years ago)

Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL syringe, Rx only, Hikma Injectables USA Inc, 36 Stults Road, Dayton, NJ 08810, NDC 63037-123-25

Affected NDC 63037-0123-25

Compare with the code on your package — it is the most precise check available.

Drug: Phenylephrine

Recalling firm
Hikma Injectables USA Inc
NDC code
63037-123-25
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0508-2024 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now completed, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Phenylephrine recalls

See all

Other recalls by Hikma Injectables USA Inc

All 2024 recalls
Class II · Moderate risk

ketamine inj 50 mg per 1 mL

Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.

Terminated Sterility / contamination Hikma Injectables USA Inc NDC 63037-137-25 D-0173-2025